Prot# D8480C00055: A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone

  • Raizer, Jeffrey J (Co-PD/PI)

Project: Research project

Project Details

Effective start/end date10/24/0810/24/11


  • AstraZeneca Pharmaceuticals LP (D8480C00055)